Microtissues®

Summary

Published in Cancers (2023), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Mueggler, Amanda, et al. An Optimized Method to Culture Human Primary Lung Tumor Cell Spheroids

🧬 Oncology

An Optimized Method to Culture Human Primary Lung Tumor Cell Spheroids

Cancers 2023 Mueggler, Amanda, et al
Cite as: Mueggler, Amanda, et al. An Optimized Method to Culture Human Primary Lung Tumor Cell Spheroids. Cancers (2023). doi:10.3390/cancers15235576 doi.org/10.3390/cancers15235576

Research Overview

Lung cancer is the leading cause of cancer death, with five-year survival under 20%. Molecular profiling guides therapy selection but cannot predict an individual patient’s response or long-term benefit, leaving a need for functional tests.

The authors developed patient-derived spheroids from surgically resected tumor and adjacent normal lung tissue using a two-step culture procedure, so both tissues could be biomimicked for in vitro drug-response testing. Flow cytometry and immunostaining characterized the cell populations, spheroid phenotype, proliferation, and apoptosis were assessed, and gene expression was compared between tumor and adjacent normal spheroids.

Key Discoveries

  • Two-step culture generated patient-derived spheroids from both lung tumor and adjacent normal tissue
  • Cell populations characterized by flow cytometry and immunostaining
  • Enables personalized in vitro drug-response testing with matched normal-tissue controls